Description
+ Include: 9 videos + 1 pdf, size: 5.87 GB
+ Target Audience: surgery physican, gastroenterology physican, hepatology physican
+ Sample video: contact me for sample video
+ Information:
Friday, November 5, 2021, 7:30 AM – 3:35 PM, Online, Detroit, MI
Exciting progress is underway regarding surgical options for the breast and axilla in neoadjuvant chemotherapy patients, lymphedema prevention. How COVID-19 has impacted screening delays and the effects of the vaccine on treatment. The evolution of the role of genomic profiling and genetic testing. Physicians involved with the diagnosis and management of breast cancer patients need to be kept apprised of new information in all of these areas.
Objectives
- Ensure physicians have a better understanding of axillary management after NAC
- Ensure physicians are more comfortable with breast imaging after patients receive COVID-19 vaccination
- Ensure physicians are more knowledgeable on how supportive services effect breast cancer and are better equipped to advise patients
- Provide current screening guideline recommendations for general and high risk populations, including gadolinium concerns
- Ensure physicians have a better understanding of the surgical prevention options for lymphedema
- Ensure physicians have a better understanding of the role of XRT in the treatment for 1-3 positive nodes
+ Topics:
Breast Lymphedema.mp4
Breast Radiation Therapy in the Time of COVID-19.mp4
Choosing Wisely When to De-Escalate Care in the Elderly.mp4
Concordance and Efficacy of Intraoperative Gross Examination of Margin.mp4
Effects of COVID on Breast Imaging Screen Delays and Vaccine Effects.mp4
Precision Medicine for Aggressive Breast Cancers.mp4
Supportive Oncology A Multidisciplinary Approach to Modern Breast Cancer Care.mp4
Trends in Adaptive Neoadjuvant Treatment.mp4
Which Stage IV Patients Should be Considered for Surgery.mp4
Brochure.pdf
Reviews
There are no reviews yet.